{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.10"},{"groupId":"OG001","spread":"0","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"description":"Quality of life questionnaire asking \"I have nausea\".","dispersionType":"Standard Deviation","groups":[{"description":"Patients undergo full-dose radiotherapy once or twice daily 5 days a week for up to 7 weeks and receive cisplatin IV over 1 hour on days 1, 22, and 43 of radiotherapy.","id":"OG000","title":"Radiation With Concurrent Cisplatin"},{"description":"Patients undergo radiotherapy as in arm I and receive fluorouracil IV and cisplatin IV continuously on days 1-4 and 22-25 of radiotherapy.","id":"OG001","title":"Radiation With Concurrent 5-FU and Cisplatin"}],"paramType":"MEAN","populationDescription":"Patients still alive from Cleveland Clinic only. University Hospital patients were not included in this analysis.","reportingStatus":"POSTED","timeFrame":"24 months from start of treatment","title":"Nausea Level","type":"SECONDARY","unitOfMeasure":"units on a scale"}